Skip to main navigation

AVLAYAH™ (tividenofusp alfa-eknm) is NOW APPROVED in the U.S. Learn more in our press release.

  • Investors & News
  • Contact Us
 Denali Therapeutics homepage
  • Investors & News
  • Contact Us
Science
Science Overview
TransportVehicle™ Platform
Publications
Partnerships & Collaborations
Product & Pipeline
Product & Pipeline Overview
Product
Pipeline
Patients
Patients Overview
Our Commitment
Advocacy
Grants & Sponsorships
Therapeutic Areas
Clinical Studies
Early Access Program
Medical Professionals
Medical Professionals Overview
Get In Touch
Clinical Studies
Recent Publications
Grants & Sponsorships
Early Access Program
About Us
About Us overview
About Us
Leadership
Careers
Careers Overview
Life at Denali
Benefits &Offerings
Internships
Postdoc Program
STEM Outreach
Science
  • TransportVehicle™ Platform
  • Publications
  • Partnerships & Collaborations
Product & Pipeline
  • Product
  • Pipeline
Patients
  • Our Commitment
  • Advocacy
  • Grants & Sponsorships
  • Therapeutic Areas
  • Clinical Studies
  • Early Access Program
  • Alzheimer's disease
  • Frontotemporal dementia (FTD)
  • Hunter syndrome (MPS II)
  • Parkinson's disease
  • Pompe Disease
  • Sanfilippo syndrome (MPS IIIA)
Medical Professionals
  • Get In Touch
  • Clinical Studies
  • Publications
  • Grants & Sponsorships
  • Early Access Program
About Us
  • About Us
  • Leadership
Careers
  • Life at Denali
  • Benefits & Offerings
  • Internships
  • Postdoc Program
  • STEM Outreach

Event Details

  • Overview

  • Press Releases

  • Events

  • SEC Filings

  • Corporate Governance

  • Analyst Coverage

Denali Analyst Call – 2026 WORLDSymposium™

Feb 5, 2026 12:30 PM PST

Register for webcast

Supporting Materials

DNLI_WORLD2026 Analyst Call Presentation 2.4 MB
DNLI WORLD 2026 Tividenodusp Alfa Platform Presentation 520.1 KB
DNLI WORLD 2026 Tividenofusp Alfa Sibling Pair Poster 670.8 KB
DNLI WORLD 2026 MPS II HEOR Poster 453.7 KB
DNLI WORLD 2026 MPS II Community Survey Poster 632.1 KB
DNLI WORLD 2026 DNL126 Platform Presentation 464.8 KB
DNLI WORLD 2026 DNL952 Ph1 Study Design Poster 1.9 MB
DNLI WORLD 2026 DNL952 Preclinical Poster 4.1 MB

Sign up for email alerts

Stay in the loop with updates on the latest Denali news delivered right to your inbox

Science
  • TransportVehicle™ Platform
  • Publications
  • Partnerships & Collaborations
Product & Pipeline
  • Product
  • Pipeline
Patients
  • Our Commitment
  • Advocacy
  • Grants & Sponsorships
  • Therapeutic Areas
  • Clinical Studies
  • Early Access Program
Medical Professionals
  • Get in Touch
  • Clinical Studies
  • Recent Publications
  • Grants & Sponsorships
  • Early Access Program
About Us
  • About Us
  • Leadership
  • Investors & News
  • Contact Us
Careers
  • Life at Denali
  • Benefits & Offerings
  • Internships
  • Postdoc Program
  • STEM Outreach
Legal
  • Privacy Policy
  • Terms of Use
  • Consumer Health Data Privacy Policy
  • Cookies Policy
  • California Compliance Declaration
  • Community Guidelines
 Denali Therapeutics corporate site

© 2026 Denali Therapeutics